Status:
UNKNOWN
Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome
Lead Sponsor:
Benha University
Conditions:
Infertility
Eligibility:
FEMALE
20-35 years
Phase:
PHASE2
PHASE3
Brief Summary
To evaluate safety and efficacy of 3-day cetrotide therapy started on day of oocyte retrieval (Day-0) in women at high-risk for development of ovarian hyperstimulation syndrome (OHSS) after gonadotrop...
Detailed Description
The current study is conducted at Assisted Reproduction Unit at Almana general Hospital, kingdom of saudi arabia.and other private centers in Egypt. The study protocol was approved by the Local Ethica...
Eligibility Criteria
Inclusion
- number of retrieved oocytes was ≥20
- mean number of follicles with a diameter of \>16 mm was ≥18
- serum E2 concentrations of ≥3500 pg/ml
- ovarian diameter on the day of ovum retrieval of \>10 cm
- presentation of evident symptoms of OHSS on the day of aspiration .
Exclusion
- 1- Absence of one or more of the items of the inclusion criteria.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT02823080
Start Date
October 1 2014
End Date
May 1 2017
Last Update
March 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benha university hospitalا
Banhā, El Qalubia, Egypt